tiprankstipranks
Advertisement
Advertisement

PSTV Stock Latest News

Plus Therapeutics files $100M mixed securities shelf
The FlyPlus Therapeutics files $100M mixed securities shelf
2d ago
PSTV
Plus announces presentation of health economics study on CNSide CSF assay
PremiumThe Fly
Plus announces presentation of health economics study on CNSide CSF assay
9d ago
PSTV
Plus Therapeutics enters pact with Ephemeral for AI execution platform
PremiumThe Fly
Plus Therapeutics enters pact with Ephemeral for AI execution platform
16d ago
PSTV
Plus Therapeutics Stockholders Back Directors and Incentive Plan
PremiumCompany Announcements
Plus Therapeutics Stockholders Back Directors and Incentive Plan
19d ago
8K
PSTV
Plus Therapeutics reports Q1 EPS ($1.05), consensus (87c)
PremiumThe Fly
Plus Therapeutics reports Q1 EPS ($1.05), consensus (87c)
19d ago
PSTV
Plus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
PremiumCompany AnnouncementsPlus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
1M ago
8K
PSTV
Plus Therapeutics regains compliance with Nasdaq minimum bid price requirement
Premium
The Fly
Plus Therapeutics regains compliance with Nasdaq minimum bid price requirement
1M ago
PSTV
PSTV Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PSTV Upcoming Earnings Report: What to Expect?
2M ago
PSTV
Plus Therapeutics Appoints New Chief Development Officer
PremiumCompany Announcements
Plus Therapeutics Appoints New Chief Development Officer
2M ago
8K
PSTV
Plus Therapeutics appoints Eric Daniels as chief development officer
PremiumThe Fly
Plus Therapeutics appoints Eric Daniels as chief development officer
2M ago
PSTV
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
PremiumCompany Announcements
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
2M ago
8K
PSTV
Plus Therapeutics granted Orphan Drug Designation for Reyobiq
PremiumThe Fly
Plus Therapeutics granted Orphan Drug Designation for Reyobiq
2M ago
PSTV
Plus Therapeutics price target lowered to $12 from $37.50 at Maxim
PremiumThe FlyPlus Therapeutics price target lowered to $12 from $37.50 at Maxim
2M ago
PSTV
Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code
Premium
The Fly
Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code
2M ago
PSTV
Plus Therapeutics’ treatment of malignant glioma granted FDA orphan designation
Premium
The Fly
Plus Therapeutics’ treatment of malignant glioma granted FDA orphan designation
2M ago
PSTV
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
PremiumCompany Announcements
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
2M ago
8K
PSTV
Plus Therapeutics Inc (USA) trading halted, news pending
PremiumThe Fly
Plus Therapeutics Inc (USA) trading halted, news pending
2M ago
PSTV
Plus Therapeutics downgraded to Hold from Buy at D. Boral Capital
PremiumThe Fly
Plus Therapeutics downgraded to Hold from Buy at D. Boral Capital
2M ago
PSTV
Plus Therapeutics announces 1-for-25 reverse stock split
PremiumThe Fly
Plus Therapeutics announces 1-for-25 reverse stock split
2M ago
PSTV
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
PremiumCompany AnnouncementsPlus Therapeutics Adds Industry Veteran Ronald Andrews to Board
2M ago
8K
PSTV
Plus Therapeutics’ CNSide assay may reduce healthcare costs
Premium
The Fly
Plus Therapeutics’ CNSide assay may reduce healthcare costs
3M ago
PSTV
Plus Therapeutics: Advancing Reyobiq Pipeline and CNSide Commercialization Underpinned by Strong Cash Runway to 2027
Premium
Ratings
Plus Therapeutics: Advancing Reyobiq Pipeline and CNSide Commercialization Underpinned by Strong Cash Runway to 2027
3M ago
PSTV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >